Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A Phase II Double-Masked, Randomized, Parallel-Group Study to Assess the Safety and Efficacy of ALTY-0501 (Doxycycline 0.025% Ophthalmic Solution) in Dry Eye Patients Exposed to the Controlled Adverse Environment (CAE)

A Phase II Double-Masked, Randomized, Parallel-Group Study to Assess the Safety and Efficacy of ALTY-0501 (Doxycycline 0.025% Ophthalmic Solution) in Dry Eye Patients Exposed to the Controlled Adverse Environment (CAE). Association for Research in Vision and Ophthalmology Meeting. 2008.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.